Clinical Trial

Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2022 (before its estimated December 23, 2023 completion). Its status may not reflect the trial's current state.
Summary
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-05-31; most recent amendment 2022-04-28.
Status change: Not Yet Recruiting → Recruiting 2020-12-22
Trial Details
NCT Number NCT03972956
Lead Sponsor Renmin Hospital of Wuhan University
Conditions Colorectal Cancer, Gastric Cancer, Inflammatory Bowel Diseases, Gastric Ulcer, Hemorrhoids, Hernia
Enrollment 1,000 participants
Start Date 2020-12-23
Primary Completion 2023-12-23 (estimated)
Study Completion 2026-12-23 (estimated)
Updated on ClinicalTrials.gov 2022-04-29